Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWB
1126
DELISTED
Great Western Bancorp, Inc.
GWB
| $15.3M | 0.01% |
427,711
+67,156
| +19% | +$2.26M |
|
1127
First Bancorp
FBP
$4.46B
| $15.3M | 0.01% |
1,383,413
+378,300
| +38% | +$4.07M |
|
1128
Cohu
COHU
$2.66B
| $15.2M | 0.01% |
988,254
+296,300
| +43% | +$4.61M |
|
1129
Regal Rexnord
RRX
$11.5B
| $15.2M | 0.01% |
186,600
+595
| +0.3% | +$47.9K |
|
|
SPR
1130
DELISTED
Spirit AeroSystems
SPR
| $15.2M | 0.01% |
+187,300
| New | +$15.8M |
|
1131
Coca-Cola
KO
$373B
| $15.2M | 0.01% |
299,000
-3,305,800
| -92% | -$162M |
|
|
CMBT
1132
CMB.TECH NV
CMBT
$4.86B
| $15.2M | 0.01% |
1,615,704
+1,153,365
| +249% | +$10.5M |
|
1133
NACCO Industries
NC
$317M
| $15.2M | 0.01% |
292,490
+28,544
| +11% | +$1.33M |
|
1134
Elbit Systems
ESLT
$36.5B
| $15.2M | 0.01% |
101,400
+2,700
| +3% | +$387K |
|
|
HTT
1135
High Templar Tech Ltd
HTT
$391M
| $15.1M | 0.01% |
2,017,900
+1,527,000
| +311% | +$10.5M |
|
1136
WisdomTree
WT
$3.44B
| $15.1M | 0.01% |
2,452,602
+108,502
| +5% | +$737K |
|
1137
A10 Networks
ATEN
$2B
| $15.1M | 0.01% |
2,218,700
+92,200
| +4% | +$604K |
|
1138
Coeur Mining
CDE
$19.3B
| $15.1M | 0.01% |
3,484,428
+976,400
| +39% | +$3.43M |
|
1139
Sibanye-Stillwater
SBSW
$7.58B
| $15M | 0.01% |
3,168,130
-764,877
| -19% | -$3.03M |
|
1140
Jack in the Box
JACK
$358M
| $15M | 0.01% |
184,700
+30,300
| +20% | +$2.45M |
|
1141
T. Rowe Price
TROW
$23.8B
| $15M | 0.01% |
136,961
-1,084,439
| -89% | -$114M |
|
|
IMGN
1142
DELISTED
Immunogen Inc
IMGN
| $15M | 0.01% |
6,922,640
-121,000
| -2% | -$286K |
|
|
AMBR
1143
DELISTED
Amber Road Inc
AMBR
| $15M | 0.01% |
1,149,600
+110,500
| +11% | +$1.24M |
|
1144
TechTarget
TTGT
$265M
| $15M | 0.01% |
706,400
+30,996
| +5% | +$579K |
|
|
LFC
1145
DELISTED
China Life Insurance Company Ltd.
LFC
| $15M | 0.01% |
1,212,835
+186,200
| +18% | +$2.36M |
|
|
ATCO
1146
DELISTED
Atlas Corp.
ATCO
| $15M | 0.01% |
1,528,600
+642,800
| +73% | +$6.19M |
|
1147
Veracyte
VCYT
$3.59B
| $15M | 0.01% |
525,500
+70,700
| +16% | +$1.77M |
|
1148
Frontline
FRO
$8.81B
| $15M | 0.01% |
1,865,252
+668,023
| +56% | +$5.32M |
|
|
IBTX
1149
DELISTED
Independent Bank Group, Inc.
IBTX
| $14.9M | 0.01% |
271,009
-23,057
| -8% | -$1.25M |
|
1150
Civeo
CVEO
$345M
| $14.9M | 0.01% |
720,833
-8,159
| -1% | -$176K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.